Toxicity of treatment regimens for drugresistant tuberculosis.
Background. The main factors reducing treatment effectiveness in patients with pulmonary tuberculosis are as follows: the growing drug resistance of mycobacteria, which necessitates the strengthening of chemotherapy regimens, the use of new antimicrobial drugs, as well as poor tolerability of treatm...
Saved in:
| Main Authors: | G. N. Mozhokina, Yu. R. Zyuzya, L. Yu. Petrova, A. G. Samoilova, I. A. Vasilyeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2022-03-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specific Manifestations of Neurotoxicity of Some Drug Combinations for Treatment of Drug Resistant Tuberculosis from the Perspective of Experimental Studies
by: G. N. Mozhokina, et al.
Published: (2023-01-01) -
Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01) -
Variety of Adverse Reactions in Rats after Administration of Combination of Anti-tuberculosis and Antimicrobial Drugs with Different Safety Profiles
by: G. N. Mozhokina, et al.
Published: (2022-11-01) -
A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01) -
Approaches to Selection of Optimal Chemotherapy Regimens in Tuberculosis Patients with Concurrent Diabetes Mellitus
by: O. G. Komissarova, et al.
Published: (2023-12-01)